Sartorius Stedim Biotech has teamed up with Wuxi AppTec to help
companies remove some of the strain of carrying out viral clearance
testing, which for large biopharmaceutical companies can carry a
price tag of up to $1m a year.
Scientists have made a remarkable discovery that could open up new
avenues in drug development resulting in novel therapies for the
treatment of poxviruses such as variola virus, the cause of
British gene therapy firm Oxford Biomedica has licensed its VSV-G
viral envelope technology for gene delivery to American biotech
company VIRxSYS which hopes it can use it to successfully produce
its promising anti-HIV/AIDS product...
Researchers are to develop new computational diagnostic methods for
key viral pathogens, which are set to make the storage, retrieval,
and exchange of molecular and diagnostic data on viral pathogens
more efficient and effective.
US firms Large Scale Biology Corp and privately-held Planet
Biotechnology have expanded their biomanufacturing program to
extract and purify the latter's lead product, CaroRx, a plant-made
antibody to control dental caries.
An ionic silver complex designed for human antimicrobial use has
received a US patent, in a move that could well see increased usage
of this technology that exhibits broad-spectrum antimicrobial
qualities as well as displaying a lack...
An opportunity to develop drugs by targeting a recently discovered,
and potentially vulnerable, intermediate stage of the viral life
cycle, could result in a new pharmaceutical treatment in the fight
against HIV and other similar...
Researchers have discovered that a certain virus appears to cloak
itself with a recently discovered gene-silencing device to evade
detection and destruction by immune cells. The study is the first
to show how a virus uses the gene...
Qiagen has acquired the PCR diagnostics company Artus, in a move
that now allows Qiagen to offer preanalytical sample preparation
and diagnostic assay solutions to its partners in molecular
diagnostics. The acquisition further allows...
REPLICor is developing a broad spectrum antiviral drug, which has
the broadest spectrum of activity in vitro ever reported for a
single chemical entity and has proved to have a devastating action
on the herpes viruses, influenza and...
Qiagen has launched an automated viral DNA and RNA purification
solution that provides improved sensitivity in purification and
detection of viral DNA and RNA from serum, plasma, and cell-free
The first molecular-scale images of DNA binding to an adenovirus
enzyme, a crucial step for a virus to cause infection, have been
produced, which shows how binding to DNA may stimulate the enzyme,
aiding to the design of new antiviral...
Scientists studying vaccinia virus, a close relative of smallpox,
have discovered that a gene necessary for virus replication also
plays a key role in turning off inflammation, a crucial antiviral
immune response of host cells.